We are now completing a study on adolescents between the ages of 12 and 16. We anticipate having that data filed here in a couple of months. We will then initiate a program for children aged 5 to 11. We are also currently conducting clinical studies, including here in Canada, for pregnant women. Those three studies are under way.
On March 8th, 2021. See this statement in context.